Historical data from 2001 to 2025 demonstrates that November and December serve as the benchmark index's most lucrative months, averaging gains of 2.5% and 2.6% respectively. Broader segments share this historical strength, alongside seasonal demand catalysts such as the November 8 Diwali festival. Despite revised valuations and typical year-end portfolio rebalancing, market experts caution that a lasting recovery necessitates improved corporate earnings and a return of foreign capital.
Key points
Seasonal patterns favor late-year equity gains, bolstered by festive sentiment and consum…: Seasonal patterns favor late-year equity gains, bolstered by festive sentiment and consumption surrounding the November 8 Diwali holiday.
Recent market corrections and subsequent valuation revisions may assist equities alongsid…: Recent market corrections and subsequent valuation revisions may assist equities alongside scheduled year-end portfolio rebalancing.
A durable market turnaround requires fundamental stabilization, specifically foreign port…: A durable market turnaround requires fundamental stabilization, specifically foreign portfolio inflows, steady global cues, and stronger corporate earnings.
Sources checked by our analysis pipeline: 1
Indian equities are heading into November after a prolonged phase of weakness, with persistent foreign investor outflows, elevated crude oil prices, rupee depreciation and global uncertainty weighing on market sentiment. The recent correction has also put the spotlight on whether the Nifty 50 can stage a recovery in the final two months of 2026 or if investors should brace for further volatility.
Historical trends, however, offer some reasons for optimism. Data from 2001 to 2025 shows that November and December have been the strongest months for the Nifty 50, delivering average returns of 2.5% and 2.6%, respectively. The index has ended November in positive territory in 15 of the past 25 years, while December has recorded gains in 17 of those 25 years, according to NSE data analysed by SAMCO Research.
With Diwali falling on 8 November this year, festive demand, improved consumption sentiment and year-end portfolio adjustments could provide additional support to equities. But will seasonal strength be enough to revive the bulls, or will global headwinds continue to cap gains? A look at 25 years of market data…
Utssav CZ Gold Jewels is rewarding investors by funding a capital expansion through its securities premium, free reserves, and retained earnings. This corporate action will effectively double the jewellery manufacturer's existing paid-up capital and outstanding shares once regulatory clearances are secured. Despite recent technical pullbacks, the move reflects substantial balance sheet strength built during an aggressive multi-fold market rally this year.
Robust economic activity and a sharp surge in imports provided a significant boost to India's fiscal receipts during the month. Net revenue experienced an even stronger expansion after accounting for taxpayer refunds, indicating healthy underlying consumption trends. Major state economies across the nation maintained solid growth trajectories, with smaller regions posting substantial momentum in their tax intake.
The Ahmedabad-headquartered bio-pharmaceutical manufacturer Concord Biotech has finalized plans to reward existing equity holders through corporate action. Investors must hold the company's stock by Tuesday, November 3, to qualify for the distribution ahead of the midweek eligibility cutoff. This corporate reward comes as the business navigates mixed trading momentum across diverse market timeframes.